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Abstract
Background: Target-primed (non-LTR) retrotransposons, such as the human L1 element, are
mobile genetic elements found in many eukaryotic genomes. They are often present in large
numbers and their retrotransposition can cause mutations and genomic rearrangements. Despite
their importance, many aspects of their replication are not well understood.
Results: We have developed a yeast model system for studying target-primed retrotransposons.
This system uses the Zorro3 element from Candida albicans. A cloned copy of Zorro3, tagged with
a retrotransposition indicator gene, retrotransposes at a high frequency when introduced into an
appropriate C. albicans host strain. Retrotransposed copies of the tagged element exhibit similar
features to the native copies, indicating that the natural retrotransposition pathway is being used.
Retrotransposition is dependent on the products of the tagged element's own genes and is highly
temperature-regulated. The new assay permits the analysis of the effects of specific mutations
introduced into the cloned element.
Conclusion:  This Zorro3 retrotransposition assay system complements previously available
target-primed retrotransposition assays. Due to the relative simplicity of the growth, manipulation
and analysis of yeast cells, the system should advance our understanding of target-primed
retrotransposition.
Background
Retrotransposons are mobile genetic elements present,
often in large numbers, in most eukaryotic genomes. They
spread through the copying of RNA transcripts into DNA
and the insertion of these DNAs into new sites in the host
genome. Most retrotransposons can be classified into one
of three classes [1]. The first of these is known as the Long
Terminal Repeat (LTR) retrotransposons. The integrated
forms of these elements are flanked by LTRs. These ele-
ments copy their RNA into DNA within cytoplasmic par-
ticles. The completed DNA copy is then moved to the
nucleus and inserted into the host genome. Members of
the second major class of retrotransposons, the tyrosine
recombinase (YR) retrotransposons [1-3], contain either
inverted repeats or split direct repeats. They are thought to
produce circular, extrachromosomal DNA intermediates
which are integrated into the host genome via the actions
of an encoded tyrosine recombinase. Members of the
third major class [4] lack extensive repeat sequences.
These elements copy their RNA into DNA directly at the
targeted insertion site, using a 3' OH exposed by nicking
of the target DNA as a primer. These elements are vari-
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ously referred to as non-LTR retrotransposons, poly-A ret-
rotransposons, retroposons or LINEs (for Long
Interspersed Nuclear Elements). Here, we shall refer to
them as target-primed (TP) retrotransposons, following
the suggestions of Curcio and Derbyshire [1].
The L1 element is the most commonly encountered TP
retrotransposon in mammals [reviewed in ref. [5]]. In
humans, L1 is the single most abundant feature in the
genome, comprising about 17% of the sequence [6], and
being responsible for at least another 11% through pro-
viding the replication machinery for processed pseudo-
genes [7], the abundant Alu elements [8] and probably
also SVA elements [9]. L1 elements are also likely to have
played an important part in the evolution of the structure
and activity of the remainder of the genome, by providing
dispersed sites of sequence similarity at which recombina-
tion can occur [10], by inserting into genes altering their
structure and/or regulation [11], and by carrying flanking
sequences with them during transposition (L1-mediated
sequence transduction) [12-17].
An intact L1 element is about 6 kb in length and consists
of two long open reading frames (ORFs) which are
flanked by 5' and 3' untranslated regions (UTRs) and sep-
arated by a short interORF region [5]. ORF1 encodes a
protein with nucleic acid-binding and nucleic acid-chap-
erone activities [18-20]. ORF2 encodes a protein with
endonuclease (EN) [21] and reverse transcriptase (RT)
[22] domains as well as a C-terminal cysteine-rich, zinc
finger-like domain (ZF) of unknown function [23]. The 5'
UTR contains an internal promoter that drives transcrip-
tion of the element [24]. The activity of this promoter may
be influenced by the upstream flanking sequence [25].
The 3' UTR contains a poly-adenylation signal and is fol-
lowed by a poly-A tail which varies in length in different
copies.
Despite the abundance and importance of TP retrotrans-
posons, many features of their replication are as yet only
poorly understood. Much of what is known is based upon
biochemical analyses of the target-primed R2 element
from  Bombyx mori [26,27]. R2 inserts at a specific site
within the B. mori ribosomal RNA gene arrays. It consists
of a single long ORF flanked by 5' and 3' UTRs. The ORF
encodes a protein with EN and RT activities. Following
translation, the proteins associate with the mRNA and the
resulting ribonucleoprotein complex then associates with
the target site in the genomic DNA. Here the EN domain
generates a single-stranded nick in the target site, exposing
a free 3'-OH group, which is then used by the RT to prime
first-strand DNA synthesis, using the R2 RNA as a tem-
plate. The latter steps of retrotransposition are not well
understood but presumably include the nicking of the sec-
ond strand of the target site, the synthesis of second-
strand DNA and the sealing of the ends. This model for
retrotransposition is thought to be applicable to all TP ret-
rotransposons [21,28]. In the case of L1 (and perhaps in
most TP elements), the retrotransposon-encoded proteins
have a strong tendency to mobilize the RNA that encoded
them, a phenomenon known as cis-preference [29]. This is
likely mediated by the nascent proteins remaining associ-
ated with the mRNA from which they were translated.
In efforts to further dissect the replication mechanisms of
TP elements, several model systems have been developed
that permit the retrotransposition of marked elements of
defined sequence to be followed in vivo. The most widely
used of these are based on human or rodent L1 elements.
By studying the effects of various mutations within the L1
sequence, and by analysing the structures of numerous
retrotransposed copies, much has been learned about the
L1 retrotransposition process and the effect this has on the
host genome [[14,21,30-37]; reviewed in ref. [38]]. Never-
theless, despite the advances resulting from these mam-
malian systems, some aspects of the retrotransposition
process, in particular the role played by host genes, might
be more easily studied in simpler systems. Assays in yeasts
such as Saccharomyces cerevisiae or  Schizosaccharomyces
pombe, with their small genomes, well understood genet-
ics and relative ease of generating host gene knockouts,
would make valuable additions to currently available
assays. Unfortunately, TP elements are not found in either
S. cerevisiae [39] or S. pombe [40], so such a system has not
been available to date. In addition, while the Tad1 TP ret-
rotransposon of the widely used fungus Neurospora crassa
has been shown to retrotranspose [41], a system permit-
ting detailed analyses of the retrotransposition of this ele-
ment has not yet been developed.
We recently reported the existence of three families of TP
elements in the yeast Candida albicans [42]. We suggested
that one of these, Zorro3, might make a useful yeast
model for TP retrotransposition as (1) it is apparently
intact (two long ORFs, the second bearing conserved EN,
RT and ZF domains), (2) it is closely related to the human
L1 element, (3) it is similar in structure to L1 (Fig. 1), with
non-overlapping ORFs, similar protein domains, and
with an ~250-bp 3' UTR terminating in a poly-A tail, and
(4) it appears to have transposed recently (as suggested by
variable banding patterns among different strains ana-
lysed by Southern blotting), which suggests that it has
recently been active and may still be so. In this report we
describe the development of an assay system for studying
the retrotransposition of Zorro3. This is the first assay sys-
tem for studying a TP retrotransposon in a simple micro-
bial model system and it should significantly advance the
study of these elements.BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
Page 3 of 16
(page number not for citation purposes)
Results
Defining the structure of a yeast TP retrotransposon
Prior to this work only one full-length sequence of Zorro3
was available (Fig. 1), together with a single sequence of a
5'-truncated element, and two partial sequences, one con-
taining a 5' end and the other a 3' end [42]. These were all
derived from the C. albicans genome sequencing project
strain, SC5314 [43]. Related empty sites were also availa-
ble for some insertions (from SC5314 and/or other
strains) allowing the 5' and 3' ends to be defined. Before
attempting to develop a retrotransposition assay, we
wished to obtain further data as to whether the one appar-
ently full-length sequence was likely to represent a func-
tional version of the element. In particular, we wished to
examine the 5' end and the interORF region in more
detail. The 5' end is unusual in that it begins with a poly-
A sequence and in that there is only a very short distance
(5 bp) between the end of the poly-A sequence and the
first available ATG codon of ORF1. For the interORF
region, we wished to check whether the non-overlapping
ORFs and a poly-A tract found between the ORFs are gen-
eral features of Zorro3 elements.
The sequences of two additional Zorro3 5' ends were
obtained by inverse PCR from C. albicans strain
ATCC10261 [GenBank:DQ239689 and Gen-
Bank:DQ239690]. Each of these elements was inserted at
a different site to any Zorro3 insertion in SC5314, in
agreement with previous results obtained by Southern
blotting [42]. The ATCC10261 elements both have 5' ends
identical to those of the two found in SC5314, i.e., begin-
ning with a poly-A tract and with only a very short 5' UTR.
In addition, comparisons between the sequences flanking
these elements and the related empty sites in SC5314 (not
shown), revealed that both elements had inserted into
short poly-A tracts, as have the elements in SC5314 [ref.
[42], and data not shown], suggesting that Zorro3 ele-
ments might preferentially integrate at such sequences.
Further sequences of the region between ORF1 and ORF2
of Zorro3 elements were obtained by PCR using DNA
from ten unrelated isolates of C. albicans. Each additional
Zorro3 sequence was found to have an interORF region
identical, or very nearly so, to that of the sequenced ele-
ment from SC5314, i.e., in all cases ORF1 and ORF2 do
not overlap and the interORF region contains an extensive
poly-A tract.
In addition, further sequences (not shown) of Zorro3-like
elements were obtained from a close relative of C. albicans,
Candida dubliniensis, both by PCR and by analysis of data
from a C. dubliniensis genome sequencing project [73].
Comparisons of the elements from two different species
assists in the identification of functionally important
sequences, as unimportant sequences will have had time
to diverge considerably. We found that the C. dubliniensis
Zorro3-like elements have similar features to the
sequenced copy of Zorro3 from C. albicans, i.e., they begin
and end in poly-A tracts, they have only very short 5'
UTRs, and ORF1 and ORF2 are non-overlapping and sep-
arated by an interORF region bearing a poly-A tract (or an
extremely A-rich sequence). Furthermore, analysis of
related empty sites suggested that these elements had all
inserted into short poly-A tracts.
Overall, these findings indicate that the sequenced version
of Zorro3 is likely to represent the intact structure of the
element, despite its several unusual features.
A retrotransposition assay for Zorro3
Constructs for studying Zorro3 retrotransposition were
built by sequentially incorporating PCR-derived
sequences into bacterial plasmids as described in the
Methods section. The construct used in much of the work
described here, pPZ3TA (Fig. 2; GenBank accession no.
EF667963), contains a full-length Zorro3 element with a
retrotransposition indicator gene inserted into its 3' UTR.
The retrotransposition indicator gene is the same as that
used previously to study retrotransposition of the C. albi-
cans LTR retrotransposon Tca2 [44], and consists of the
ORF of the C. albicans URA3 gene and 136 bp of its pro-
moter sequence, with the ORF disrupted by an antisense
intron. This indicator gene is inserted into the Zorro3 3'
UTR so that the URA3 ORF is on the opposite strand to the
Zorro3 ORFs. The Zorro3 element in pPZ3TA is preceded
by 1023 bp from the C. albicans ACT1 gene promoter
region and is followed by 151 bp of its natural 3' context,
then 391 bp from the ACT1 terminator region. The plas-
mid also contains an allele of the C. albicans IMH3 gene
[45,46] that confers resistance to the antibiotic mycophe-
nolic acid (MPA), for selection of the plasmid in C. albi-
cans, and the ORF region of the C. albicans RP10 gene [47].
The plasmid can be linearised at a unique Pin  AI site
within the RP10 ORF to target integration to the genomic
Structures of the human L1 element and Zorro3 of C. albi- cans Figure 1
Structures of the human L1 element and Zorro3 of 
C. albicans. Shaded boxes represent ORFs; the approximate 
positions of conserved protein-coding domains are indicated. 
The ORFs are flanked by untranslated regions (thick black 
lines). The border between the 3' UTR of each element and 
flanking genomic DNA (dashed lines) consists of a poly-A 
tract (An). Zorro3 also has a poly-A sequence at its 5' end 
and between its ORFs. The L1 element is flanked by short 
duplications of the target sequence (black triangles).
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RP10 locus. This site has been suggested as a good site for
integration and expression of transforming DNA in C.
albicans [48].
The strategy by which plasmid pPZ3TA can be used to
study retrotransposition of the cloned Zorro3 element
(Fig. 2) is similar to that used previously for other systems
[14,49,50]. First, the plasmid is introduced into a auxo-
trophic strain of C. albicans, CAI4 [51], which has had
both copies of its URA3  gene deleted, using the MPA-
resistance gene for selection. The transformants will ini-
tially remain auxotrophs as the marker gene on the plas-
mid is inactive due to the antisense intron. Splicing of the
intron from a sense transcript of the marked Zorro3 ele-
ment, and retrotransposition of the spliced transcript, i.e.,
its copying into DNA and integration into the host
genome, will, however, result in the appearance of a stably
integrated, functional URA3 gene. Expression of this gene
would confer a URA3+ phenotype on the host cell. Thus,
retrotransposition events can be detected by the appear-
ance of URA3+ colonies on the appropriate selective
media.
A marked Zorro3 element retrotransposes in C. albicans
Plasmid pPZ3TA was introduced into C. albicans strain
CAI4 using selection for resistance to MPA. The resulting
MPA-resistant transformants were isolated, grown in liq-
uid culture, then plated onto selective media lacking urid-
ine and incubated at 22°, 27° or 37°C. No colonies arose
on the 37° plates, but, after four to five days, colonies,
representing potential retrotransposition events, began to
appear on the 22° and 27° plates (Fig. 3).
To test whether these colonies result from genuine retro-
transposition events (rather than from some other unde-
fined process) the structures of their URA3  genes were
examined. PCR amplification of DNA isolated from the
URA3+ colonies using primers that flank the intron inser-
tion site in the antisense ura3 gene produced two bands,
one of a size expected from the introduced tagged Zorro3
element and the other slightly smaller (not shown). For
two independent colonies this smaller band was cloned
and sequenced. In both cases a URA3 gene from which the
antisense intron had been precisely removed was
detected. This indicates that the marker gene is derived
from a spliced mRNA molecule and that the element has
therefore been retrotransposed.
URA3+ colonies from the Zorro3 retrotransposition assay Figure 3
URA3+ colonies from the Zorro3 retrotransposition 
assay. An example of a retrotransposition assay plate. C. albi-
cans ura3- strain CAI4, transformed with a construct con-
taining a wild-type tagged Zorro3 element, was plated onto 
medium lacking uridine. The photo shows the plate after 3 
weeks incubation at 22°C. No colonies were ever observed 
when parental (non-transformed) CAI4 was tested under 
identical condiions.
An assay for Zorro3 retrotransposition Figure 2
An assay for Zorro3 retrotransposition. (A) The cloned 
Zorro3 element has a retrotransposition indicator gene 
(URA3 promoter, URA3P, and URA3 ORF, disrupted by an 
antisense intron) inserted into its 3' UTR. The element is 
preceded by the C. albicans ACT1 promoter and followed by 
the ACT1 terminator. The transforming vector also contains 
sequences for selection in bacteria (Ampicillin resistance) and 
in C. albicans (MPA resistance). The entire construct can be 
linearised at a unique Pin AI site (not shown) within a copy of 
the RP10 gene to target integration to the genomic RP10 
locus. The first step of retrotranspositon is transcription to 
give a full-length mRNA (B). The intron in this RNA is then 
removed by splicing (C). Reverse transcription and integra-
tion of the spliced RNA results in a functional and stably inte-
grated URA3 gene and confers a URA3+ phenotype on the 
host cell (D).
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Eight different URA3+ derivatives, four from each of two
independent pPZ3TA transformants, were analysed by
Southern blotting to determine whether the retrotrans-
posed copies of the tagged Zorro3 element had inserted
into different sites in the genome, as expected for genuine
retrotransposition events (Fig. 4). This was indeed found
to be the case. Each URA3+ derivative had a single addi-
tional band hybridising to a URA3 probe relative to their
ura3- parents, and these bands were of different sizes in
each of the eight strains analysed. This work suggests that
the URA3+ cells derived from pPZ3TA transformants are a
result of genuine retrotransposition events, and further-
more, they show that most, if not all, of these colonies
have arisen independently.
The 3' ends of retrotransposed Zorro3 elements
As a first step towards a detailed examination of the struc-
ture of the retrotransposed copies of the tagged Zorro3
elements, the 3' ends of 30 independent copies were
amplified by inverse PCR and sequenced (Table 1). The 3'
end was chosen for initial analysis for two reasons: one, it
is close to the marker gene, so a primer straddling the
insertion site of the intron in the marker can be used,
which makes the reaction specific for retrotransposed cop-
ies of the element (i.e. endogenous elements and the
donor marked elements, still containing the intron, are
not amplified), and two, TP retrotransposons are often
variably 5' truncated, leading to difficulties in designing a
primer pair capable of amplifying all 5' ends.
We found that 27 of the 30 new retrotransposed copies of
Zorro3 extended to the natural 3' end of Zorro3, one
ended upstream of the natural 3' end within the Zorro3 3'
UTR, and two ended even further upstream within the
promoter region of the URA3 marker gene. None of the 30
contained any 3' transduced sequence, i.e., the 3' flanking
sequence of the donor element (151 bp of its natural con-
text followed by the ACT1 terminator) was not retrotrans-
posed. All 30 copies (including those terminating
upstream of the natural 3' end) ended in a poly-A tract.
These varied in length between seven and 43 bp, with 21
of the 30 being between 15 and 25 bp long, inclusive.
Insertion sites of Zorro3 elements
Sequencing of the inverse PCR products revealed not only
the structure of the 3' ends of the elements but also their
3' flanking sequences. The latter could then be used to
determine (by comparison with the known C. albicans
genome sequence [52]) the nature of the insertion site
prior to the retrotransposition event and the context of the
insertion site in relation to other genomic features. The
insertion sites were found to be distributed throughout
the  C. albicans genome, with representatives found on
seven of the eight chromosomes and more events on the
larger chromosomes (1, 2 and R) than on smaller ones
(Table 1). Most elements were found to have inserted at
unique sites, although three pairs of elements inserted at
the same sites were found (insertions 12.4 and 14.22,
22.1 and 14.18, and 14.1 and 14.15). For two of these
pairs the same site was certainly targeted independently as
the URA3+ colonies were isolated independently from
ura3- parents. Each of the new insertion sites was distinct
from any previously identified Zorro3 insertion site. The
new retrotransposed copies were all found to have inte-
grated at short poly-A sequences, varying in length
between 4 and 21 consecutive A residues, with 25 of 30
being between 9 and 15 bp (inclusive) in length. None of
the elements had inserted into an ORF, despite coding
regions comprising 61.5% of the C. albicans genome [53].
Many of the elements, however, had inserted very close to
coding regions (Additional file 1; examples shown in Fig.
5) and there seemed to be a bias towards locations near
the 5' ends of ORFs, with 16 of 30 insertions being
between divergently transcribed ORFs, 13 between those
Genomic Southern blot showing new copies of tagged  Zorro3 elements in URA3+ derivatives Figure 4
Genomic Southern blot showing new copies of 
tagged Zorro3 elements in URA3+ derivatives. The 
blot was probed with the C. albicans URA3 gene. Each lane 
contains DNA cut with Hin dIII. Lane M contains the trans-
forming vector. CAI4 is the ura3- host strain. The 'A' lanes 
contain DNA from two independent ura3- transformants. 
Lanes B-E contain DNA from four independent URA3+ 
derivatives. The additional bands in these lanes represent 
newly retrotransposed copies of the tagged Zorro3 element. 
Bands at 6.5 kb (the same size as that present in the marker 
lane) likely represent tandem integrations of the vector in 
the genome. The bands at 12.3 kb are of the size expected 
for the sequence at the border between the tandem copies 
of the vector and the genomic insertion site.
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Table 1: Features of retrotransposed copies of tagged Zorro3.
Insert no. Assembly 19 contigA Chromo- some Length of target 
poly-A tract (bp)
5' endB Length of 5' 
poly-A tract (bp)
3' endC Length of 3' poly-A tract (bp)
12.1 x0254 (94830 F) 3 10 5' truncated (ORF2) 10 Native 20
12.2 x0257 (1660 F) 2D 9/11E ACT1 promoter (52–53) 6 URA3 promoter 31
12.4 10119 (254650 F) 2 12 Native (recombinant) 26F Native 20
22.1 x0163 (134670 R) 1 12 Native (recombinant) 20F Native 20
13.3 x0234 (49865 R) 2 9 Native (recombinant) 26F Native 20
13.4 10231 (18975 F) 4 10 Native 22 Native 13
13.5 x0143 (96420 F) 2 12 Native 28 3' UTR 7
13.6 x0163 (203035 F) 1 13 Native (recombinant) 20F URA3 promoter 43
13.7 x0119 (244340 F) 2 12 Native (recombinant) 26F Native 20
13.11 10063 (36770 F) R 11 Native (recombinant) 34F Native 20
13.13 x0216 (94130 R) 1 9 None (recombinant?)G NA Native 12
13.14 10212 (133650 R) 4 10 None (recombinant?)G NA Native 11
13.15 x0196 (22910 F) 2 21 ACT1 promoter (20–27) 20 Native 17
13.17 x0166 (27780 R) 4 12 None (recombinant) NA Native 25
13.18 x0163 (15740 F) 1 12 Native ~160H Native 24
14.1 x0087 (72350 R) 1 10 Native 19 Native 18
14.4 20236 (26790 R) 3 7 ACT1 promoter (48–51) 30 Native 17
14.5 x0218 (144180 R) 1 17 Native ~100 Native 24
14.7 x0188 (25725 F) R 9 Native 52 Native 18
14.11 x0139 (200180 F) 2 11 None (recombinant) NA Native 15
14.13 10020 (2820 R) 1 10 ACT1 promoter (20–27) 87 Native 24
14.15 x0087 (72350 R) 1 10 None (recombinant) NA Native 12
14.16 2500 (72900 R) 3 11 ACT1 promoter (20–27) 10 Native 14
14.17 x0073 (13260 R) 1 10 Native 36 Native 14
14.18 x0163 (134670 R) 1 12 Native 24 Native 25
14.19 2506 (28525 R) 7 4 Native 27 Native 16
14.20 20161 (92640 R) R 10 Native 27 Native 16
14.21 20216 (97180 F) 1 18 Native 51 Native 17
14.22 10119 (254650 F) 2 12 ACT1 promoter (20–27) 25 Native 15
14.24 20155 (47610 R) 5 10 Native 37 Native 21
A Assembly 19 contigs generally come in pairs of similar sequence representing portions of putative homologous chromosome pairs. Members of 
the pairs are distinguished by either a 1 or 2 at the start of the contig number, eg. 10254 and 20254. In the cases where the Zorro3 insertion site 
can be assigned to a particular homolog the number of that contig is shown. In cases where the insertion could lie on either of the homologs the 
first digit of the contig number is replaced by an x. The positions of the insertions within the contigs and their orientations, forward (F) or reverse 
(R), are shown in parentheses.
B The nature of the 5' end of each element is given. For a majority of elements the 5' ends are the same as those of the full-length endogenous 
insertions (Native). Several elements were greater than full-length, i.e., extending back into the ACT1 promoter sequence. The precise lengths of 
ACT1 promoter sequences in these elements could not be determined as in all cases the similarity between the retrotransposed sequences and the 
ACT1 promoter sequences ended within runs of A residues. Some elements had recombined with endogenous full-length Zorro3 elements (Native 
(recombinant)). Some elements had recombined with an endogenous 5' truncated/inverted Zorro3 element in such a way that the resulting 
insertion lacks a 5' end (None (recombinant); see text).
C The nature of the 3' end of each element is given. For most elements the 3' ends are the same as those of the endogenous insertions (Native). 
Some end earlier within either the Zorro3 3' UTR or within the URA3 promoter sequence.
D Insertion site corresponds to chromosome 2 in C. albicans strain WO-1. The chromosomal origin of contigs 19–10257 and 19–20257 in strain 
SC5314 is not known due to conflicing data.
E The length of the target poly-A tract varies in the two homologs.
F The length of the 5' poly-A tract in each of these insertions is determined by the length of the 5' poly-A tract of the endogenous element that was 
involved in the recombination event.
G Data not conclusive for these two insertions.
H Several T residues are found within the 5' poly-A tract of this element. NA Not applicable.BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
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in a head-to-tail arrangement and only one between ORFs
that are convergently transcribed (Additional file 1). No
particular association could be identified between the
insertion sites and other identifiable genomic features,
such as tRNA genes, subtelomeric regions, or retrotrans-
poson LTRs and other repetitive sequences. The findings
suggest that the tagged Zorro3 elements specifically inte-
grate at poly-A sequences and may be biased towards pro-
moter regions. This is similar to the potential preferences
[outlined above and in ref. [42]] that have been identified
for endogenous Zorro3 insertions.
The 5' ends of retrotransposed Zorro3 elements
Once the 3' flanking sequence of a particular Zorro3 inser-
tion was identified we used the C. albicans genome
sequence data to predict what the 5' flanking sequence
would be. Primers designed to this sequence were then
used in PCRs in combination with a series of reverse prim-
ers along the length of Zorro3 (thus allowing for the pos-
sibility of variably 5' truncated elements) to identify the 5'
end of the insertion. By this method we identified the 5'
ends of 19 of the 30 insertions (Table 1). Twelve of these
are full-length elements, ending precisely at the natural 5'
end. Six insertions are greater than full-length, i.e., extend-
ing beyond the natural 5' end to include up to 53 bp of the
3' end of the ACT1 promoter sequence. Similar transduc-
tions of 5' flanking sequence have been observed for L1
elements [6,34]. The 19th insertion is 5' truncated within
the ORF2 region. Each element begins with a poly-A
sequence, between six and ~160 residues in length. The 5'
flanking sequence of each insertion extends to the
genomic poly-A tract that appears to have been targeted by
the element, i.e., there are no large deletions or duplica-
tions at the target sites (Fig. 5B &5C).
The 5' ends of the remaining eleven insertions could not
be identified by the above method. The 5' end of one of
these insertions was, however, subsequently identified
using inverse PCR and it was found to coincide precisely
with the 5' end of one of the endogenous full-length
Zorro3 insertions. This suggested that a recombination
event had occurred between the new insertion of the
tagged element and the endogenous element. We there-
fore designed primers to regions upstream of each of the
full-length Zorro3 elements in the genome (two endog-
enous elements and the element on the transforming vec-
tor) and used these primers in PCRs in combination with
primers specific to each of the tagged elements whose 5'
ends had not yet been identified. An additional five ele-
ments (six in total) were found to have recombined with
full-length endogenous insertions (Table 1). Three had
recombined with an endogenous insertion on chromo-
some 2, one with an endogenous insertion on chromo-
some R and two with a full-length element on
chromosome 1 that had been introduced on the transfor-
mation vector. In each case the new retrotransposed ele-
ment and the endogenous full-length element that it had
recombined with were located on the same chromosome.
The distance between the insertion sites for elements of
each pair ranged from about 40 bp to about 115 kb (not
shown). Five of the six pairs of recombining elements
were located in the same orientation and the recombina-
Insertion sites of retrotransposed copies of tagged Zorro3 Figure 5
Insertion sites of retrotransposed copies of tagged 
Zorro3. (A) Genomic features in the 2.5 kb surrounding the 
insertion sites of tagged Zorro3 elements (dashed line) for 
the first nine events analysed are shown. ORFs and their 5'-3' 
orientations are indicated by the black arrows. Introns are 
indicated by white boxes within the arrows. (ORF locations 
were derived from the known C. albicans genome sequence 
[52]). (B and C). An example of the 5' end (B) and 3' end (C) 
sequence of an insertion of a tagged Zorro3 element (inser-
tion no. 12.1). The poly-A tract at the target site is indicated 
in boldface. The extent of sequence matching the tagged 
Zorro3 element is indicated by underlining. The target site 
sequence in this case comes from the genome sequence, 
contig19-10254 (Table 1).
12.1
12.2
12.4
22.1
13.3
13.4
13.5
13.6
13.7
Tagged Zorro3
1kb
A
B
C
ACCCGATGGAAGATGCAAGACAAAAAAAAAAGAAAGAAAAAAAATTTTATCTTATTTT... 19-10254
|||||||||||||||||||||||||||||||
ACCCGATGGAAGATGCAAGACAAAAAAAAAAAATTAACATATCTAGGAGTACCGATGA...
                               5’ truncated in Zorro3 ORF2
ACCCGATGGAAGATGCAAGACAAAAAAAAAAGAAAGAAAAAAAATTTTATCTTATTTT... 19-10254
                     |||||||||||||||||||||||||||||||||||||
TTGAGAAAGGAAAAAAAAAAAAAAAAAAAAAGAAAGAAAAAAAATTTTATCTTATTTT...
  Zorro3, 3’ end
...
...
...
...BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
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tion events presumably resulted in the deletion of the
intervening sequences. Events very similar to these have
been found associated with new L1 retrotransposition
events in mammalian cells [32,34,35]. These chimaeric
elements were proposed to arise during target-primed
reverse transcription by recombination between the sin-
gle-stranded L1 cDNAs produced during the initial stages
of the reaction and the endogenous elements. A similar
process could have given rise to the chimaeric Zorro3
insertions.
The 5' ends of the remaining five insertions could not be
detected by any of the above methods. Unexpectedly,
however, for several of these elements we could obtain
PCR products using single primers located downstream of
the 3' ends of the elements. Sequencing of these PCR
products and additional PCR experiments (not shown)
indicated that these elements had undergone recombina-
tions with an endogenous Zorro3 element located on
chromosome R that is 5' truncated and also includes 1.4
kb of inverted Zorro3 sequence. The recombination
events had lead to the duplication of the 3' flanking
sequence to each end of the now recombinant 5' trun-
cated/inverted element and the loss of the 5' flanking
sequence. None of the 3' flanking sequences of tagged
insertions involved in these events were located on chro-
mosome R. The recombination events generating these
elements must have resulted from inter-chromosomal
recombination and presumably generated dicentric
recombinant chromosomes whose resolution would have
required chromosomal breakage.
Zorro3 retrotransposition is temperature-regulated
As alluded to above, strains carrying the tagged Zorro3 ele-
ment did not give rise to URA3+ colonies at 37°C, but
produced an abundance of URA3+ derivatives at lower
temperatures. To analyse this phenomenon in more detail
we measured the transposition rate at 22°, 27° and 37°.
We did not observe any retrotransposition at 37°, whereas
numerous events were observed at 27°, and the rate was
increased about a further ten-fold at 22° (Fig. 6), suggest-
ing that some aspect of the Zorro3 retrotransposition
pathway is strongly affected by temperature. It is not yet
known what this is, but possibilities include some tem-
perature-sensitive aspect of enzyme activity or perhaps the
involvement of some temperature-sensitive (unstable)
RNA secondary structure in the process. This fortuitous
temperature-sensitivity of Zorro3 retrotransposition pro-
vides a convenient means of regulating the process, i.e.,
retrotransposition can be inhibited by maintaining the
cells at 37°C, then allowed to proceed by moving them to
a lower temperature. It is interesting to note that a temper-
ature-dependent affect on retrotransposition was also
observed for the C. albicans Tca2 retrotransposon [44],
although in this case retrotransposition was more fre-
quent at higher temperatures. Likewise, Ty1 of S. cerevisiae
is temperature-sensitive, with retrotransposition events
most frequent at about 24°C and very rare at 37°C
[54,55].
Zorro3 retrotransposition utilises its own proteins
We next asked whether Zorro3 retrotransposition is
dependent on the ORFs of the cloned element or whether
it is due to activation in trans by endogenous retroele-
ments or cellular proteins. We made several mutant ele-
ments carrying specific alterations in the Zorro3 sequence.
One mutant, pPZ3TAΔPA, has an extensive deletion that
extends from a Pst I site at position 1337 of the Zorro3
sequence to a Pst I site at position 3724 and removes the
last 531 bp of ORF1, the interORF region and the first
1682 bp of ORF2. A second mutant, pZ3BN2, has an
inframe stop codon introduced near the start of ORF2,
downstream of the first conserved domains of the EN-
coding sequence. A third mutant, pZ3BN3, has a
frameshift introduced into ORF2 at the same site as the
stop codon in pZ3BN2 above. These mutant elements
were transformed into C. albicans and the associated retro-
transposition frequency was measured and compared
with that of wild-type elements (Fig. 7, Table 2). Cells car-
rying pPZ3TAΔPA did not give rise to any URA3+ cells.
Cells carrying pZ3BN2 or pZ3BN3 did produce URA3+
derivatives but at less than 5% the frequency of cells car-
rying wild-type elements. These results suggest that retro-
transposition of a Zorro3 element, for the most part,
requires its ORFs to be intact. One potential alternative
explanation, however, is that the mutations in the ORFs of
Temperature-dependence of Zorro3 retrotransposition Figure 6
Temperature-dependence of Zorro3 retrotransposi-
tion. Liquid cultures of two ura3- transformants containing 
tagged Zorro3 elements were aliquoted onto 3 sets of plates 
lacking uridine. Each set of plates was incubated at 22°, 27° 
or 37°C for 14 days. The lines show the combined results of 
daily counts of URA3+ colonies for each set of plates. Identi-
cal trends were observed for each independent analysis (not 
shown).
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these elements result in less stable RNA molecules, and it
is reduced RNA levels, rather than an absence of appropri-
ate proteins, that results in the reduced retrotransposition
frequency. To test this we measured the Zorro3 RNA levels
in cells carrying wild-type and mutant elements (Fig. 8,
Table 3). Cells carrying pZ3BN2 or pZ3BN3 were found to
have, on average, higher Zorro3 RNA levels than cells with
the wild-type element. The RNA levels in cells with the
internally deleted element were measured as somewhat
lower than those of cells with the wild-type element, but
this slight reduction is unlikely to account for the com-
plete absence of retrotransposition in these cells. Overall,
these results show that most (> 95%) of the retrotranspo-
sition that is observed for the tagged wild-type elements in
this system is dependent upon the proteins produced by
the tagged element. A low background rate of retrotrans-
position associated with some mutants might be due to
the mutations being slightly leaky or a result of trans-acti-
vation by endogenous elements (see the Discussion).
Analysis of specific mutants of Zorro3
One of the main potential uses for a yeast TP retrotranspo-
sition assay is the study of the contribution of specific
sequences to the retrotransposition process. To begin an
analysis of the sequences important for Zorro3 retrotrans-
position we made three more mutant elements. In the first
additional mutant, pZ3BN4, the first ATG codon in ORF2
was changed to ACG. This triplet is of particular interest as
the means by which ORF2 is translated in L1 and L1-like
elements is not well understood. Because ORF2 is the sec-
ond ORF in a dicistronic transcript, its translation is
Expression and splicing of tagged Zorro 3 RNA Figure 8
Expression and splicing of tagged Zorro 3 RNA. (A) 
Map of tagged Zorro3 element showing primer locations. 
URNAR2 straddles the intron insertion site. (B) RT-PCR of 
tagged Zorro3 RNA. Genomic DNA and total RNA were 
separately extracted from a C. albicans CAI4 derivative stably 
transformed with a plasmid carrying a marked Zorro3 ele-
ment. The RNA was reverse transcribed using oligonucle-
otide ZRNAR2 as a primer. PCRs were then performed 
using oligonucleotides URNAR1 and ZRNAR1 as primers. 
Templates in the reactions were as follows: lane 1, total RNA 
reverse transcribed with primer ZRNAR2; lane 2, total RNA 
not reverse transcribed; lane 3, genomic DNA; lane 4, no 
template. The intron-containing PCR amplicon obtained 
using primers URNAR1 and ZRNAR1 would be 364 bp long. 
Amplification of reverse transcribed RNA from which the 
intron had been precisely spliced would produce an amplicon 
of 280 bp. Primer URNAR2 was used (in combination with 
ZRNAR1) to quantify the tagged Zorro3 RNA (see text).
1234
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Retrotransposition assay plates for wild-type and mutant  Zorro3 elements Figure 7
Retrotransposition assay plates for wild-type and 
mutant Zorro3 elements. Photographs are shown of rep-
resentative plates inoculated with 250 μl of cultures of C. albi-
cans cells transformed with wild-type or mutant Zorro3 
elements and incubated at 22°C for 21 days. No colonies 
were ever observed when the non-transformed parent strain 
was tested under identical conditions.BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
Page 10 of 16
(page number not for citation purposes)
unlikely to be initiated simply following cap-recognition
and scanning. In the next mutant, pZ3BN5, an extremely
A-rich sequence in the interORF region
(TA4CA5CTGATA5CACTAGA19GAGA3GACA2CA3) was
replaced with an Asp 718I site (GGTACC). In the third,
pZ3BN6, a missense mutation (N17A) was made in ORF2
converting a highly conserved Asn codon in the endonu-
clease coding region to an Ala codon. A similar mutation
at the homologous position of the human L1 element
(N14A) apparently eliminates L1 EN activity and reduces
retrotransposition frequency to 1% of wild-type [21].
The mutant elements were transformed into C. albicans
and the retrotransposition frequency associated with each
measured and compared to that of wild-type elements
(Table 2). The levels of Zorro3 RNA for each were also
measured and were all found to be similar to cells bearing
the wild-type construct (Table 3).
For cells carrying pZ3BN4, the retrotransposition fre-
quency was reduced to less than 5% of that of cells bearing
wild-type elements, a similar level to that found with ele-
ments bearing stop codons or frameshifts within ORF2.
This indicates that the first ATG codon in ORF2 is impor-
tant for Zorro3 retrotransposition (see the Discussion).
The deletion of the A-rich sequence in the interORF region
(pZ3BN5) reduces the retrotransposition frequency to
about half that of wild-type elements (Table 2), suggesting
that this sequence is also involved in some way in retro-
transposition, but that it is perhaps not as critical as the
structure of ORF2.
Like the ORF2 nonsense, frameshift and ATG mutations,
the N17A missense mutation in the EN coding region of
ORF2 (pZ3BN6) reduces the retrotransposition frequency
to less than 5% of that of the wild-type element. This sug-
gests that the Zorro3 endonuclease is involved in the
majority of the observed retrotransposition events.
Discussion
Here we have described a system for studying the lifecycle
of a TP retrotransposon in a yeast. This is the first such sys-
tem in a experimentally tractable microorganism. Retro-
transposed copies of the marked Zorro3 element that the
system uses resemble endogenous insertions suggesting
that the natural retrotransposition pathway is being
Table 3: Comparisons of relative retrotransposition frequencies and RNA levels for Zorro3 mutants
Transforming plasmid Mutation Relative retrotransposition 
frequency (% of wild-type)A
Relative Zorro3 RNA levels (% of 
wild-type)B
pZ3BN1 Wild-type 100 100
pZ3BN2 ORF2 stop 8 288
pZ3BN3 ORF2 frameshift 1 209
pZ3BN4 ORF2 ATG → ACG 18 130
pZ3BN5 InterORF poly-A deletion 15 98
pZ3BN6 EN missense 5 55
pPZ3TAΔPA Internal deletion 0 34
A The relative retrotransposition frequency was calculated in the same way as for Table 2, but data was taken from only the particular 
transformants in which RNA levels were also measured.
B Zorro3 RNA levels were measured as described in the text. The Zorro3 RNA levels in each RNA sample were then normalized against the ACT1 
RNA levels in the same RNA sample and averaged for each set of transformants containing the same plasmid construct.
Table 2: Retrotransposition frequencies of wild-type and mutated tagged Zorro3 elements.
Transforming 
plasmid
Mutation Retrotransposition 
frequency (URA3+ 
colonies/106 cells)A, B
Relative 
retrotransposition 
frequency (% of wild-type)
No. of 
assaysC
Individual retrotransposition frequencies
pZ3BN1 Wild-type 4.47 100 10 (8) 0.664, 0.882, 1.130, 1.631, 1.641, 1.783, 2.344, 2.989, 15.339, 16.368
pZ3BN2 ORF2 stop 0.20 4.4 8 (6) 0.037, 0.043, 0.051, 0.129, 0.148, 0.170, 0.211, 0.795
pZ3BN3 ORF2 frameshift 0.16 3.6 5 (5) 0.000, 0.033, 0.053, 0.250, 0.469
pZ3BN4 ORF2 ATG → 
ACG
0.20 4.5 4 (4) 0.021, 0.107, 0.333, 0.353
pZ3BN5 InterORF poly-A 
deletion
2.20 49.2 9 (7) 0.110, 0.262, 0.263, 0.290, 0.329, 0.345, 0.608, 1.875, 15.739
pZ3BN6 EN missense 0.09 1.9 5 (5) 0.000, 0.015, 0.065, 0.093, 0.257
pPZ3TAΔPA Internal deletion 0.00 0.0 8 (6) 0.000, 0.000, 0.000, 0.000, 0.000, 0.000, 0.000, 0.000,
A The numbers of URA3+ colonies were counted after 21 days incubation at 22°C.
B No URA3+ colonies were ever observed with the parental strain, CAI4, under identical conditions.
C The number of independent transformants analysed is shown in parentheses.BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
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employed. Retrotransposition is dependent on the ele-
ment's own internal sequence, as the introduction of
debilitating mutations greatly reduces the rate of, or elim-
inates, retrotransposition. Retrotransposition occurs suffi-
ciently frequently to allow the process to be studied by
comparing the retrotransposition frequencies of wild-type
elements and elements carrying specific mutations. This
yeast system complements other currently available sys-
tems for studying TP retrotransposons, which involve the
analysis of tagged elements in mammalian cells
[14,21,29,30,33,36,37]. For instance, it is simpler to grow
and experimentally manipulate yeast cells than cultured
mammalian cells. Certain experiments can be performed
in yeast, such as comparing retrotransposition frequencies
in multiple strains with different host genes deleted, that
would currently be impractical, if not impossible, to per-
form in mammalian cells. In addition, the acquisition and
interpretation of experimental data should be simpler in a
yeast system due to the small size of yeast genomes, the
low number of endogenous retrotransposon copies and
the possibility than even this small number of endog-
enous insertions could be specifically deleted. While cer-
tain features of the L1 system and other TP
retrotransposons will only be revealed by experiments
performed in their natural hosts, this Zorro3 assay should
make a very useful addition to the currently available sys-
tems for studying general features of TP retrotransposi-
tion.
The use of this assay system has already uncovered some
interesting aspects of Zorro3 retrotransposition. For
instance, we found that Zorro3 appears to always integrate
at poly-A sequences. This preference may represent an
adaptation to provide a large number of potential inser-
tion sites, as such sequences appear to be much more
common in the C. albicans genome than would be
expected by chance: in a random sample of Assembly 19
contigs containing 595,932 bp of genomic DNA (4% of
the 15 Mb genome) we identified 299 poly-A or poly-T
(i.e., poly-A on the complementary strand) sequences 10
or more bases in length. This 596 kb random sample of
the genome contained 66.7% A or T residues, so the
number of 10-bp poly-A or poly-T stretches expected by
chance can be estimated as about 20 (i.e., 0.33410  ×
595932 × 2). Poly-A sequences 10 bases in length thus
appear about 15 times more frequently than expected.
Assuming that the sample analysed is representative of the
genome, we estimate that there are about 7500 poly-A
stretches 10 or more bases long in the haploid C. albicans
genome. Given this number of potential Zorro3 insertion
sites it is interesting that in our sample of 30 new inser-
tions we identified three pairs of elements that had inde-
pendently inserted at the same sites. This finding suggests
that additional factors may be involved in target site selec-
tion for Zorro3, for example, proximity to RNA polymer-
ase II promoter regions (see below).
Targeting of poly-A sequences may also be an integral part
of the retrotransposition process for Zorro3: for minus
strand synthesis, the Zorro3 endonuclease would cleave
the strand complementary to the target poly-A sequence,
i.e., a poly-T sequence. This poly-T 'flap' could then
anneal to the poly-A tract at the 3' end of the Zorro3
mRNA and the 3' OH group of the T residue adjacent to
the nick could be used as a primer for minus strand DNA
synthesis. For plus strand DNA synthesis, the target poly-
A tract exposed by synthesis of minus-strand DNA onto
the target's complementary poly-T tract, would anneal to
the poly-T tract at the 3' end of the Zorro3 minus-strand
DNA (corresponding to the poly-A tract at the 5' end of
the mRNA) and a 3' OH group exposed by nicking within
the target poly-A sequence could be used to prime plus-
strand DNA synthesis. Thus, annealing between
sequences at the target and the 5' and 3' ends of the Zorro3
element could assist in directing the TP reverse transcrip-
tion reactions to the correct 5' and 3' ends, and thus pro-
mote the formation of full-length (potentially
retrotransposition-competent) progeny elements. Inter-
estingly, the apparent target preference for Zorro3 is simi-
lar to that for L1 [56], which preferentially integrates at
runs of A residues downstream of T residues (TT/AAAA,
where/represents the insertion site of the 3' end). Zorro3
and L1 elements may have a similar mechanism for
attaching the 3' end of the transcript to the genomic target
to initiate the TP reverse transcription reaction.
We also observed a bias against Zorro3 insertions within
ORFs (with none of the 30 new insertions analysed here
lying within an ORF, despite ORFs comprising more than
half the genome) and an apparent bias for Zorro3 inser-
tions a short distance (< 1000 bp) upstream of ORFs, with
17 out of 30 insertions being within 500 bp of the start of
an ORF and 23 out of 30 within 1000 bp. This may simply
reflect the location of poly-A sequences in the genome, or
it may correspond to regions with appropriate chromatin
structure for endonuclease binding, or it may be a specific
adaptation to direct integration to sites where the element
is likely to be expressed (i.e. close to promoter/enhancer
sequences), while minimising disruption to the host
genome.
Some interesting aspects of Zorro3 retrotransposition
were also uncovered by the study of elements carrying spe-
cific mutations. For example, the finding that Zorro3 ele-
ments with nonsense or frameshift mutations in ORF2
can still give rise to retrotransposition events at a detecta-
ble frequency suggests either that a low level of nonsense
suppression or frameshifting is occurring to allow the
occasional translation of ORF2, or, perhaps more likely,BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
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that a lack of ORF2 translation can be complemented in
trans at a low frequency by ORF2 protein produced by
endogenous Zorro3 insertions. In support of this possibil-
ity, previous work has shown that the endogenous Zorro3
elements are expressed at a readily detectable level [42]
and so may be capable of supplying trans-acting proteins.
If trans-activation is occurring then it is interesting to con-
sider why RNA derived from the Zorro3 element carrying
the large internal deletion is apparently unable to be trans-
complemented. One possible explanation is that the
extensive deletion in this mutant has removed a sequence
which is strictly cis-acting. The most obvious difference in
the mutations borne by these elements is that in the inter-
nal deletion mutant both ORF1 and ORF2 are likely inac-
tivated, whereas only ORF2 is inactivated in the other two.
It may be that the product of ORF2 can act in trans at some
frequency but the product of ORF1 is strictly cis-acting.
The results for the mutant in which the first ATG codon in
ORF2 is changed to ACG, which show that retrotransposi-
tion is reduced to a similar level as that for the ORF2 non-
sense and frameshift mutants, suggest that this ATG
codon is required for proper ORF2 translation. This is of
particular interest as the mechanism by which ORF2 is
translated in Zorro3 and other TP elements with non-
overlapping ORFs, such as mammalian L1, is not known
at present, although mechanisms such as internal initia-
tion or reinitiation have been suggested [57-59]. The
results for Zorro3 appear to contrast with those from
mammalian L1 elements in that whereas changing the
first ATG of ORF2 in L1 to a nonsense codon severely
reduced the frequency of retrotransposition, changing it
to any other sense codon still allowed for high levels of
retrotransposition [59].
The Zorro3 retrotransposition assay system has a number
of features which could be improved. In particular, the
variability in retrotransposition frequency seen among
independent transformants with identical constructs is
quite high, and appears to be higher than might be
expected simply due to stochastic variation. The source of
the variability is currently uncertain, but could arise due to
the transforming plasmids integrating into the genome in
different copy numbers resulting in different expression
levels and therefore different retrotransposition frequen-
cies. If this is the case then the variability might be reduced
by expressing the element from an episomal (non-integra-
tive) vector. Unfortunately, the currently available episo-
mal vectors for C. albicans [60,61] replicate at low copy
numbers, are very unstable, and are prone to randomly
integrating into the host genome at a high frequency any-
way. These would probably add to the variation rather
than reduce it. Another feature of the current assay that
might be improved is the Zorro3 retrotransposition fre-
quency, which is quite low in comparison to that of L1 –
about 4.5 events per million cells for wild-type Zorro3
compared to as many as 1000 or more per million cells for
wild-type L1s [14] (and even higher for extensively modi-
fied synthetic L1s [33]). Future attempts to optimise the
Zorro3 system may result in increased retrotransposition
frequencies.
One possible way of improving the Zorro3 system would
be to transfer it to S. cerevisiae. However, the successful
expression of C. albicans genes in S. cerevisiae is often not
a trivial matter, due to the nonstandard genetic code used
by C. albicans (in which CUG codons are translated as ser-
ine rather than leucine [62]), which may require that all
such codons in a C. albicans gene are converted to other
serine codons prior to expression in S. cerevisiae. If, how-
ever, the Zorro3 system could be successsfully transferred
to S. cerevisiae, then this would allow the many genetic
tools developed for this species to be employed in the
analysis of the retrotransposon. For instance, the contri-
bution of various host genes to the retrotransposition
process could be studied by comparing the frequency of
retrotransposition in each strain of the S. cerevisiae knock-
out collection [63]. The potential of the Zorro3 system to
function in S. cerevisiae is the subject of ongoing research.
Conclusion
We have developed a yeast model system for studying tar-
get-primed retrotransposition. Similar to the way in which
the study of specific yeast LTR retrotransposons, such as
Ty1 and Ty3, has made an enormously valuable contribu-
tion to our general understanding of LTR elements, we
hope that this yeast Zorro3 system will make a valuable
contribution to our general understanding of target-
primed retrotransposons.
Methods
Strains and culture conditions
Candida albicans strains used were CAI4 [51], a ura3-
derivative of the genome sequencing project strain
SC5314 [43], and ATCC10261 [64]. Candida dubliniensis
strains used were CD36, CD41 [65] and CD43 [66].
Strains were grown on YPD medium (1% yeast extract, 2%
peptone, 2% glucose) or YNB (0.67% yeast nitrogen base,
1% glucose). When necessary YNB was supplemented
with uridine (160 mg/l).
Standard yeast methods
C. albicans DNA isolations, Southern blotting and trans-
formations were as described previously [44]. CAI4 cells
were transformed with 3–4 μg of vector linearised with
either Pin AI or its isoschizomer Age I. For selection of C.
albicans transformants, mycophenolic acid (MPA; Invitro-
gen), dissolved in absolute ethanol, was added to a final
concentration of 5 μg/ml).BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
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DNA manipulations
Recombinant DNA manipulations were performed using
standard techniques [67]. Standard Polymerase Chain
Reactions (PCRs) were performed on a Eppendorf Master-
cycler gradient instrument, using Expand Hi Fi or Expand
Long Template PCR systems (Roche). Oligonucleotides
were from Proligo. Sequences of oligos used for plasmid
constructions and RT-PCR are available in Additional file
2. Sequences of oligos used for amplification of the ends
of specific Zorro3 retrotransposition events are available
from the authors on request. Sequencing was performed
on a ABI3730 instrument at the Allan Wilson Centre [68].
RNA isolation and RT-PCR
C. albicans RNA was isolated essentially by the method of
Schmitt et al. [69] except that cells were grown in
YNB+uridine medium. Contaminating DNA was
destroyed by treatment with recombinanat, RNase-free
DNase I (Roche) as recommended by the manufacturer.
Each RNA sample was then separately reverse transcribed
with primers ARNAR2 (actin) or ZRNAR2 (Zorro3) using
Transcriptor Reverse Transcriptase (Roche) according to
the manufacturer's instructions. Initial RT-PCRs were per-
formed as for the standard PCRs above. Quantitative PCRs
were performed using a Roche LightCycler 2.0 instrument
and LightCycler FastStart DNA MasterPLUS SYBR Green I
reaction mix in 20 μl capillaries. ACT1 cDNAs were ampli-
fied using primers ARNAF2 and ARNAR1. Marked Zorro3
cDNAs were amplified using primers URNAR2 and
ZRNAR1. The relative amount of Zorro3 RNA in each
sample was normalized to the amount of ACT1 RNA in
the same sample.
Sequence data
Sequence data for Candida albicans was obtained from the
Stanford Genome Technology Center website [70].
Sequencing of Candida albicans was accomplished with
the support of the NIDR and the Burroughs Wellcome
Fund. Data analysed in this report was from Assembly 19
[52].  Candida dubliniensis sequence data was obtained
from the Sanger Institute [73].
Plasmid constructions
The Zorro3 retrotransposition vector was made by the
sequential assembly of PCR-derived sequences into
pUC19-based plasmids as described below. The complete
structures of the plasmids used for retrotransposition
assays are also described in the Results section. The struc-
tures of all clones, and junctions produced by subcloning
steps, were verified by sequencing.
The retrotransposition assay plasmid pPZ3TA was con-
structed as follows. First, a region of the SC5314 genome
containing the last 144 bp of the 3' UTR of a full-length
Zorro3 element, the poly-A tail (20 consecutive A resi-
dues) and 151 bp of 3' flanking sequence was amplified
using primers RAZ3F2 and RAZ3R2 (corresponding to
bases 7097–7410 of contig19-10054). The PCR product
was cut with Sal I and Sph I and cloned into Sal I/Sph I-cut
pUC19 to give plasmid pZ3.31A. A second PCR product
was generated using primers RAZ3F1 and RAZ3R1, corre-
sponding to Zorro3 from a unique central Xba I site to the
point in the 3' UTR immediately upstream of that
included in pZ3.31A. This PCR product was cut with Asp
718I and Sal I and cloned into Asp 718I/Sal I-cut pZ3.31A
to give plasmid pZ3XS3.1A. This plasmid contains the
entire back end of Zorro3 and 151 bp of 3' flanking
sequence and has a unique Sal I site inserted into the 3'
UTR. Next, a PCR product containing the C. albicans URA3
gene disrupted by an antisence intron was generated from
plasmid pRUIA [44] using primers U3F1 and U3R1. The
PCR products were cut with Xho I and cloned into the Sal
I site of pZ3XS3.1A to give plasmid pZ3UIA3A. In this
plasmid the URA3 gene is orientated such that the URA3
ORF and the Zorro3 ORF are on opposite strands. Next,
the front half of Zorro3, including 20 consecutive A resi-
dues at the 5' end and extending as far as the unique cen-
tral  Xba  I site, was amplified by PCR using primers
RAZ3F3 and RAZ3R4. The PCR product was cut with Sac I
and Xba I and cloned into Sac I/Xba I-cut pK19 (a plasmid
similar to pUC19 but which confers kanamycin resistance
instead of ampicillin resistance) to give plasmid pZ3.51B.
The insert of pZ3.51B was then excised as a Sac I-Xba I
fragment and cloned into pZ3UIA3A to give plasmid
pZ3AM1A.
The terminator region of the C. albicans ACT1 gene [71]
was amplified by PCR from SC5314 genomic DNA using
primers TAF1 and TAR1. The PCR product was cut with Sal
I and Sph I and cloned into Xho I/Sph I-cut pZ3AM1A to
give plasmid pZ3TA.
The C. albicans RP10 gene [47] was amplified using prim-
ers R10F1 and R10R1. The PCR product was cut with Bam
HI and Pst I and cloned into Bam HI/Pst I-cut pK19 to give
plasmid pRP10.1A.
An allele of the C. albicans IMH3 gene [45,46] that confers
resistance to high levels of the antibiotic mycophenolic
acid (MPA) was amplified from plasmid pSFI1A [ref. [72];
kindly provided by Dr Joachim Morschhauser and Dr Ger-
wald Kohler], using primers I3F1 and I3R1. The PCR
product was cut with Eco RI and Bam HI and cloned into
Eco RI/Bam HI-cut pRP10.1A to give plasmid pR10I31C.
The IMH3/RP10 genes of pR10I31C were cut out with Sal
I and cloned into the Xho I site of pZ3TA to give plasmid
pZTMAA.BMC Genomics 2007, 8:263 http://www.biomedcentral.com/1471-2164/8/263
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The promoter region of the C. albicans ACT1 gene was
amplified by PCR from SC5314 genomic DNA using
primers ACTF1 and ACTR1. The PCR product was cut with
Xba I and cloned into the Spe I site immediately upstream
of the 5' end of the Zorro3 element in pZTMAA to give
plasmid pPZ3TA, the final plasmid on which the retro-
transposition assay is based.
A derivative of pPZ3TA containing a deletion within the
Zorro3 sequence was constructed by cleaving the plasmid
with  Pst  I and self-ligating to produce plasmid
pPZ3TAΔPA. In this plasmid, the Zorro3 element lacks all
sequences between a Pst I site near the middle of ORF1
and a Pst I site near the middle of ORF2, but is otherwise
identical to pPZ3TA.
Several specific mutants of the tagged Zorro3 element
were created by first replacing a 410 bp fragment of
pPZ3TA between a unique Bfu  AI cleavage site 6 bp
upstream of the ORF1 stop codon and a unique Nsi I site
220 bp downstream of the start of ORF2 with a Bfu AI-Nsi
I fragment containing a chloramphenicol resistance gene,
amplified using primers CATF1 and CATR1 from a pBlue-
script derivative (pBCTim1A) containing a modified clon-
ing cassette (unpublished), to produce plasmid
pZ3ΔBN.CAT1A. Six different PCR products of the Zorro3
Bfu AI-Nsi I fragment, each containing either the wild-type
sequence or one of five specific mutations, were then used
to replace the Bfu AI-Nsi I fragment of pZ3ΔBN.CAT1A,
giving plasmids pZ3BN1 (wild-type) and pZ3BN2 to
pZ3BN6 (five different mutants). The wild-type sequence
was amplified using primers MZ3F1 and MZ3R1. The
pZ3BN2 mutant (containing a stop codon in ORF2) was
produced using primers MZ3F1 and MZ3R4. The pZ3BN3
mutant (containing a frameshift in ORF2) was produced
using primers MZ3F1 and MZ3R5. The pZ3BN4 mutant
(in which the first ATG codon in ORF2 was changed to
ACG) was produced by combining PCR products made
using primers MZ3F1+MZ3R2 and MZ3F2+MZ3R1. The
pZ3BN5 mutant (in which an A-rich sequence in the inter-
ORF region was replaced with an Asp 718I site) was pro-
duced by combining PCR products made using primers
MZ3F1+MZ3R3 and MZ3F3+MZ3R1. The pZ3BN6
mutant (in which a conserved Asn codon within the EN
coding region was replaced with an Ala codon (N17A))
was produced by combining PCR products made using
primers MZ3F1+MZ3R6 and MZ3F4+MZ3R1.
Zorro3 retrotransposition assay
CAI4 transformants containing marked copies of Zorro3
were grown at 37°C in liquid YNB medium supple-
mented with uridine and MPA for two days. Multiple aliq-
uots (250 μl each) were then plated onto sets of YNB
plates (usually eight plates per transformant) and incu-
bated at the desired temperature. Counts of colonies were
then made daily for several weeks beginning after three or
four days. Estimates of the numbers of cells on the retro-
transposition assay plates were made by plating 250 μl
aliquots of serial 10-fold dilutions of the original liquid
culture onto YNB plates supplemented with uridine.
Plates were incubated at the same temperature as the assay
plates. Colonies were counted after 2–4 days. Note that
the liquid cultures were grown at 37°C because it was
found that retrotransposition did not occur at this temper-
ature, thus ensuring that colonies that arose on the plates
were due to independent retrotransposition events, rather
than potentially being clones of a single event that
occurred within the culture.
Accession numbers
Accession numbers are as follows: Full-length Zorro3,
GenBank:AF254443; Zorro3 expression vector pPZ3TA,
GenBank:EF667963; 5' end of Zorro3 insertion A from
ATCC10261, GenBank:DQ239689; 5' end of Zorro3
insertion B from ATCC10261, GenBank:DQ239690.
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Mycophenolic Acid; ORF, Open Reading Frame; PCR,
Polymerase Chain Reaction; RT, Reverse Transcriptase; TP,
Target-Primed; UTR, Untranslated Region; ZF, Zinc Fin-
ger.
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